Terns Pharmaceuticals Inc... (TERN)

2.94

0.02 (0.68%)

At close: Apr 28, 2025, 3:59 PM

2.87

-2.55%

After-hours: Apr 28, 2025, 04:34 PM EDT

Terns Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-88.85M	-90.21M	-60.34M	-50.16M	-40.57M	-68.82M	-18.02M
Depreciation & Amortization	896K	881K	1.03M	512K	394K	195K	65K
Stock-Based Compensation	15.63M	25.54M	10.77M	8.15M	1.69M	668K	234K
Other Working Capital	4.75M	142K	-315K	-3.15M	6.21M	1.05M	-840K
Other Non-Cash Items	-2.09M	-5.03M	81K	879K	2.92M	-246K	-307K
Deferred Income Tax	23K	141K	392K	219K	693K	206K	307K
Change in Working Capital	4.38M	1.29M	-1.04M	-1.43M	5.06M	1.77M	-352K
Operating Cash Flow	-70.02M	-67.39M	-49.11M	-41.83M	-29.81M	-66.22M	-18.07M
Capital Expenditures	-42K	-52K	-275K	-340K	-584K	-900K	-244K
Cash Acquisitions	n/a	n/a	22K	119.36K	-7.28K	2.96K	12.04M
Purchase of Investments	-169.94M	-275.78M	-139.73M	-166.3M	-715K	-58.38M	-6.95M
Sales Maturities Of Investments	157.57M	237.85M	117.73M	46.94M	7.99M	55.43M	2.42M
Other Investing Acitivies	n/a	n/a	-22K	-119.36K	7.28K	-2.96K	-4.53K
Investing Cash Flow	-12.41M	-37.99M	-22.27M	-119.7M	6.69M	-3.86M	-4.78M
Debt Repayment	n/a	n/a	n/a	n/a	16.88M	58K	58K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.68M	340K	-158K	-1.97M	-738K	4K	12.05M
Financial Cash Flow	164M	41.95M	167.5M	134.39M	85.52M	62K	99.76M
Net Cash Flow	81.51M	-63.31M	95.54M	-27.16M	62.48M	-70.15M	77.02M
Free Cash Flow	-70.06M	-67.44M	-49.38M	-42.17M	-30.39M	-67.12M	-18.32M